Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP2K1 | Q02750 | 20/20 | 0.76 |
| ▸ | MAP2K2 | P36507 | 2/20 | 0.54 |
| ▸ | MAP2K5 | Q13163 | 1/20 | 0.54 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.49 |
| ▸ | IARS2 | Q9NSE4 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31096355 | 1.00 | MAP2K1 (0.76) | MAP2K1MAP2K2MAP2K5PRKCZIARS2 | |
| SCHEMBL28645657 | 1.00 | MAP2K1 (0.76) | MAP2K1MAP2K2MAP2K5PRKCZIARS2 | |
| SCHEMBL24407570 | 1.00 | MAP2K1 (0.76) | MAP2K1MAP2K2MAP2K5PRKCZIARS2 | |
| SCHEMBL24407510 | 1.00 | MAP2K1 (0.76) | MAP2K1MAP2K2MAP2K5PRKCZIARS2 | |
| SCHEMBL24407608 | 0.91 | MAP2K1 (0.63) | MAP2K1MAP2K2MAP2K5PRKCZIARS2 | |
| SCHEMBL24407573 | 0.89 | MAP2K1 (0.60) | MAP2K1MAP2K2MAP2K5 | |
| SCHEMBL24407522 | 0.89 | MAP2K1 (0.60) | MAP2K1MAP2K2MAP2K5 | |
| SCHEMBL26047554 | 0.89 | MAP2K1 (0.60) | MAP2K1MAP2K2MAP2K5 | |
| SCHEMBL26047576 | 0.85 | MAP2K1 (0.55) | MAP2K1MAP2K2MAP2K5 | |
| SCHEMBL31096306 | 0.83 | MAP2K1 (0.55) | MAP2K1MAP2K2PRKCZIARS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119215031-A | Arylaniline and heteroaryl aniline compounds for the treatment of skin cancer | 恩福莱克逊治疗有限公司 | 2024-12-31 | — | — | CN | disclosed |
| CN-113645964-B | Arylaniline and heteroaryl aniline compounds for fetal treatment | 恩福莱克逊治疗有限公司 | 2024-10-11 | — | — | CN | disclosed |
| CN-113660931-B | Arylaniline and heteroaryl aniline compounds for the treatment of skin cancer | 恩福莱克逊治疗有限公司 | 2024-10-11 | — | — | CN | disclosed |
| CN-113473986-B | Naphthyridoneaniline compounds for the treatment of skin disorders | 恩福莱克逊治疗有限公司 | 2024-10-11 | — | — | CN | disclosed |